> top > docs > PMC:7268883 > annotations

PMC:7268883 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1 47-55 Disease denotes COVID-19 MESH:C000657245
4 195-203 Species denotes patients Tax:9606
5 165-173 Disease denotes COVID-19 MESH:C000657245
13 366-374 Species denotes patients Tax:9606
14 294-302 Disease denotes COVID-19 MESH:C000657245
15 359-365 Disease denotes Cancer MESH:D009369
16 432-440 Disease denotes infected MESH:D007239
17 444-452 Disease denotes COVID-19 MESH:C000657245
18 462-471 Disease denotes inability MESH:D007319
19 560-577 Disease denotes pancreatic cancer MESH:D010190
22 658-681 Disease denotes pancreatic associations MESH:D010195
23 732-740 Disease denotes COVID-19 MESH:C000657245
26 1218-1226 Disease denotes COVID-19 MESH:C000657245
27 1376-1384 Disease denotes COVID-19 MESH:C000657245
31 1629-1636 Species denotes patient Tax:9606
32 1600-1608 Disease denotes COVID-19 MESH:C000657245
33 1693-1712 Disease denotes pancreatic diseases MESH:D010182
44 1895-1905 Species denotes SARS-CoV-2 Tax:2697049
45 2150-2158 Species denotes patients Tax:9606
46 2225-2233 Species denotes patients Tax:9606
47 1863-1882 Disease denotes coronavirus disease MESH:D018352
48 1884-1892 Disease denotes COVID-19 MESH:C000657245
49 1947-1955 Disease denotes COVID-19 MESH:C000657245
50 1956-1966 Disease denotes infections MESH:D007239
51 2141-2149 Disease denotes COVID-19 MESH:C000657245
52 2239-2256 Disease denotes pancreatic cancer MESH:D010190
53 2267-2286 Disease denotes pancreatic diseases MESH:D010182
66 2346-2354 Species denotes patients Tax:9606
67 2576-2584 Species denotes patients Tax:9606
68 2719-2727 Species denotes patients Tax:9606
69 2339-2345 Disease denotes cancer MESH:D009369
70 2392-2400 Disease denotes infected MESH:D007239
71 2404-2412 Disease denotes COVID-19 MESH:C000657245
72 2595-2603 Disease denotes infected MESH:D007239
73 2607-2615 Disease denotes COVID-19 MESH:C000657245
74 2630-2639 Disease denotes inability MESH:D007319
75 2712-2718 Disease denotes cancer MESH:D009369
76 2771-2788 Disease denotes pancreatic cancer MESH:D010190
77 2846-2854 Disease denotes COVID-19 MESH:C000657245
80 3145-3153 Species denotes patients Tax:9606
81 3074-3082 Disease denotes COVID-19 MESH:C000657245
88 3292-3315 Disease denotes pancreatic associations MESH:D010195
89 3338-3351 Disease denotes Pancreas Club MESH:D010190
90 3362-3377 Disease denotes Pancreatic Club MESH:D010195
91 3521-3538 Disease denotes Pancreatic Cancer MESH:D010190
92 3555-3587 Disease denotes Pancreatic Ductal Adenocarcinoma MESH:D021441
93 3649-3678 Disease denotes Cystic Tumors of the Pancreas MESH:D003550
98 3965-3973 Disease denotes COVID-19 MESH:C000657245
99 4148-4156 Disease denotes COVID-19 MESH:C000657245
101 4455-4463 Disease denotes COVID-19 MESH:C000657245
107 4951-4983 Disease denotes Pancreatic ductal adenocarcinoma MESH:D021441
108 4985-5001 Disease denotes bile duct cancer MESH:D001650
109 5026-5041 Disease denotes adenocarcinomas MESH:D000230
110 5055-5083 Disease denotes papillary mucinous neoplasms MESH:D000077779
111 5097-5129 Disease denotes pancreatic neuroendocrine tumors MESH:D018358
113 5747-5755 Disease denotes COVID-19 MESH:C000657245
115 6315-6327 Species denotes participants Tax:9606
117 6647-6655 Disease denotes COVID-19 MESH:C000657245
123 6845-6853 Species denotes patients Tax:9606
124 6688-6696 Disease denotes COVID-19 MESH:C000657245
125 6858-6866 Disease denotes COVID-19 MESH:C000657245
126 6964-6972 Disease denotes COVID-19 MESH:C000657245
127 7090-7098 Disease denotes COVID-19 MESH:C000657245
129 7354-7362 Disease denotes COVID-19 MESH:C000657245
131 7962-7970 Species denotes patients Tax:9606
140 9045-9048 Gene denotes ten Gene:6503
141 9014-9017 Gene denotes Ta Gene:6503
142 8983-8986 Gene denotes agr Gene:6503
143 8395-8403 Species denotes patients Tax:9606
144 8572-8579 Species denotes patient Tax:9606
145 8717-8725 Species denotes patients Tax:9606
146 8737-8745 Disease denotes COVID-19 MESH:C000657245
147 8927-8935 Disease denotes COVID-19 MESH:C000657245
151 9290-9297 Species denotes patient Tax:9606
152 9224-9232 Disease denotes COVID-19 MESH:C000657245
153 9354-9373 Disease denotes pancreatic diseases MESH:D010182
169 9552-9555 Gene denotes nte Gene:6503
170 9867-9875 Species denotes Patients Tax:9606
171 10086-10094 Species denotes patients Tax:9606
172 9655-9663 Disease denotes COVID-19 MESH:C000657245
173 9716-9733 Disease denotes pancreatic cancer MESH:D010190
174 9886-9894 Disease denotes COVID-19 MESH:C000657245
175 9899-9905 Disease denotes cancer MESH:D009369
176 10053-10058 Disease denotes death MESH:D003643
177 10077-10085 Disease denotes COVID-19 MESH:C000657245
178 10103-10109 Disease denotes cancer MESH:D009369
179 10240-10246 Disease denotes cancer MESH:D009369
180 10354-10360 Disease denotes tumors MESH:D009369
181 10510-10547 Disease denotes hepato-pancreato-biliary malignancies MESH:D020065
182 10900-10912 Disease denotes malignancies MESH:D009369
183 11010-11018 Disease denotes COVID-19 MESH:C000657245
199 11325-11333 Species denotes Patients Tax:9606
200 11611-11619 Species denotes patients Tax:9606
201 11702-11710 Species denotes patients Tax:9606
202 11957-11964 Species denotes patient Tax:9606
203 12034-12042 Species denotes patients Tax:9606
204 12237-12245 Species denotes patients Tax:9606
205 12683-12691 Species denotes patients Tax:9606
206 11358-11391 Disease denotes postoperative respiratory failure MESH:D012131
207 11693-11701 Disease denotes COVID-19 MESH:C000657245
208 12048-12056 Disease denotes COVID-19 MESH:C000657245
209 12087-12104 Disease denotes pancreatic cancer MESH:D010190
210 12309-12326 Disease denotes Pancreatic cancer MESH:D010190
211 12590-12598 Disease denotes COVID-19 MESH:C000657245
212 12788-12807 Disease denotes respiratory failure MESH:D012131
213 12946-12979 Disease denotes postoperative respiratory failure MESH:D012131
215 13013-13021 Disease denotes COVID-19 MESH:C000657245
226 13104-13112 Species denotes patients Tax:9606
227 13425-13437 Species denotes Corona Virus Tax:11118
228 13515-13523 Species denotes patients Tax:9606
229 13687-13695 Species denotes patients Tax:9606
230 13771-13779 Species denotes patients Tax:9606
231 13129-13137 Disease denotes COVID-19 MESH:C000657245
232 13177-13185 Disease denotes COVID-19 MESH:C000657245
233 13678-13686 Disease denotes COVID-19 MESH:C000657245
234 13751-13759 Disease denotes COVID-19 MESH:C000657245
235 13791-13799 Disease denotes infected MESH:D007239
244 13823-13831 Species denotes patients Tax:9606
245 13925-13933 Disease denotes COVID-19 MESH:C000657245
246 13934-13943 Disease denotes infection MESH:D007239
247 14059-14067 Disease denotes COVID-19 MESH:C000657245
248 14076-14085 Disease denotes mortality MESH:D003643
249 14108-14114 Disease denotes cancer MESH:D009369
250 14320-14328 Disease denotes COVID-19 MESH:C000657245
251 14329-14338 Disease denotes infection MESH:D007239
253 14388-14405 Disease denotes Pancreatic Cancer MESH:D010190
276 14448-14456 Species denotes patients Tax:9606
277 14486-14493 Species denotes patient Tax:9606
278 14607-14615 Species denotes patients Tax:9606
279 14749-14757 Species denotes patients Tax:9606
280 14872-14879 Species denotes patient Tax:9606
281 14958-14966 Species denotes patients Tax:9606
282 15186-15194 Species denotes patients Tax:9606
283 15510-15517 Species denotes patient Tax:9606
284 15707-15715 Species denotes patients Tax:9606
285 15763-15771 Species denotes patients Tax:9606
286 15917-15925 Species denotes patients Tax:9606
287 14462-14479 Disease denotes pancreatic cancer MESH:D010190
288 14899-14916 Disease denotes pancreatic cancer MESH:D010190
289 15156-15173 Disease denotes pancreatic cancer MESH:D010190
290 15370-15387 Disease denotes pancreatic cancer MESH:D010190
291 15492-15509 Disease denotes pancreatic cancer MESH:D010190
292 15547-15562 Disease denotes pancreas cancer MESH:D010190
293 15634-15651 Disease denotes pancreatic cancer MESH:D010190
294 15698-15706 Disease denotes COVID-19 MESH:C000657245
295 15745-15762 Disease denotes pancreatic cancer MESH:D010190
296 15938-15946 Disease denotes COVID-19 MESH:C000657245
297 15961-15978 Disease denotes pancreatic cancer MESH:D010190
304 16267-16275 Species denotes patients Tax:9606
305 16299-16307 Species denotes patients Tax:9606
306 16126-16132 Disease denotes cancer MESH:D009369
307 16149-16157 Disease denotes COVID-19 MESH:C000657245
308 16258-16266 Disease denotes COVID-19 MESH:C000657245
309 16292-16298 Disease denotes cancer MESH:D009369
312 16386-16398 Disease denotes Malignancies MESH:D009369
313 16408-16425 Disease denotes Pancreatic Cancer MESH:D010190
323 16475-16481 Disease denotes cancer MESH:D009369
324 16499-16516 Disease denotes pancreatic cancer MESH:D010190
325 16627-16644 Disease denotes pancreatic cancer MESH:D010190
326 16719-16748 Disease denotes extrahepatic bile duct cancer MESH:D001650
327 16776-16791 Disease denotes adenocarcinomas MESH:D000230
328 17027-17034 Disease denotes cancers MESH:D009369
329 17077-17085 Disease denotes bleeding MESH:D006470
330 17087-17104 Disease denotes bowel obstruction MESH:D012778
331 17190-17197 Disease denotes cancers MESH:D009369
333 17331-17363 Disease denotes Premalignant Pancreatic Diseases MESH:D010182
341 17421-17453 Disease denotes premalignant pancreatic diseases MESH:D010182
342 17487-17499 Disease denotes pancreatitis MESH:D010195
343 17505-17533 Disease denotes infected pancreatic necrosis MESH:D019283
344 17589-17609 Disease denotes chronic pancreatitis MESH:D050500
345 17613-17621 Disease denotes infected MESH:D007239
346 17622-17641 Disease denotes pancreatic necrosis MESH:D019283
347 17747-17757 Disease denotes malignancy MESH:D009369
351 17978-17986 Species denotes patients Tax:9606
352 17904-17913 Disease denotes mortality MESH:D003643
353 18044-18052 Disease denotes COVID-19 MESH:C000657245
357 19350-19358 Species denotes patients Tax:9606
358 18845-18853 Disease denotes COVID-19 MESH:C000657245
359 19082-19095 Disease denotes insufficiency MESH:D000309
363 19886-19898 Species denotes participants Tax:9606
364 19934-19946 Species denotes participants Tax:9606
365 19774-19793 Disease denotes pancreatic diseases MESH:D010182
371 20156-20164 Species denotes patients Tax:9606
372 20263-20271 Species denotes patients Tax:9606
373 20115-20123 Disease denotes COVID-19 MESH:C000657245
374 20281-20289 Disease denotes COVID-19 MESH:C000657245
375 20290-20309 Disease denotes pancreatic diseases MESH:D010182
380 20411-20418 Disease denotes cancers MESH:D009369
381 20430-20446 Disease denotes bile duct cancer MESH:D001650
382 20475-20490 Disease denotes adenocarcinomas MESH:D000230
383 20592-20600 Disease denotes COVID-19 MESH:C000657245
389 20697-20710 Disease denotes Pancreas Club MESH:D010190
390 20721-20736 Disease denotes Pancreatic Club MESH:D010195
391 20880-20897 Disease denotes Pancreatic Cancer MESH:D010190
392 20914-20946 Disease denotes Pancreatic Ductal Adenocarcinoma MESH:D021441
393 21008-21021 Disease denotes Cystic Tumors MESH:D052177

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 3338-3346 Body_part denotes Pancreas http://purl.org/sig/ont/fma/fma7198
T2 3670-3678 Body_part denotes Pancreas http://purl.org/sig/ont/fma/fma7198
T3 4985-4994 Body_part denotes bile duct http://purl.org/sig/ont/fma/fma9706
T4 13343-13348 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T5 15547-15555 Body_part denotes pancreas http://purl.org/sig/ont/fma/fma7198
T6 16465-16474 Body_part denotes bile duct http://purl.org/sig/ont/fma/fma9706
T7 16693-16697 Body_part denotes hand http://purl.org/sig/ont/fma/fma9712
T8 16719-16741 Body_part denotes extrahepatic bile duct http://purl.org/sig/ont/fma/fma14678
T9 17087-17092 Body_part denotes bowel http://purl.org/sig/ont/fma/fma7199
T10 18599-18604 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T11 20430-20439 Body_part denotes bile duct http://purl.org/sig/ont/fma/fma9706
T12 20697-20705 Body_part denotes Pancreas http://purl.org/sig/ont/fma/fma7198
T13 21029-21037 Body_part denotes Pancreas http://purl.org/sig/ont/fma/fma7198

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 3338-3346 Body_part denotes Pancreas http://purl.obolibrary.org/obo/UBERON_0001264
T2 3670-3678 Body_part denotes Pancreas http://purl.obolibrary.org/obo/UBERON_0001264
T3 4985-4994 Body_part denotes bile duct http://purl.obolibrary.org/obo/UBERON_0002394
T4 4985-4989 Body_part denotes bile http://purl.obolibrary.org/obo/UBERON_0001970
T5 4990-4994 Body_part denotes duct http://purl.obolibrary.org/obo/UBERON_0000058
T6 13343-13348 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T7 15547-15555 Body_part denotes pancreas http://purl.obolibrary.org/obo/UBERON_0001264
T8 16465-16474 Body_part denotes bile duct http://purl.obolibrary.org/obo/UBERON_0002394
T9 16465-16469 Body_part denotes bile http://purl.obolibrary.org/obo/UBERON_0001970
T10 16470-16474 Body_part denotes duct http://purl.obolibrary.org/obo/UBERON_0000058
T11 16693-16697 Body_part denotes hand http://purl.obolibrary.org/obo/UBERON_0002398
T12 16719-16741 Body_part denotes extrahepatic bile duct http://purl.obolibrary.org/obo/UBERON_0003703
T13 16732-16741 Body_part denotes bile duct http://purl.obolibrary.org/obo/UBERON_0002394
T14 16732-16736 Body_part denotes bile http://purl.obolibrary.org/obo/UBERON_0001970
T15 16737-16741 Body_part denotes duct http://purl.obolibrary.org/obo/UBERON_0000058
T16 18599-18604 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T17 20430-20439 Body_part denotes bile duct http://purl.obolibrary.org/obo/UBERON_0002394
T18 20430-20434 Body_part denotes bile http://purl.obolibrary.org/obo/UBERON_0001970
T19 20435-20439 Body_part denotes duct http://purl.obolibrary.org/obo/UBERON_0000058
T20 20697-20705 Body_part denotes Pancreas http://purl.obolibrary.org/obo/UBERON_0001264
T21 21029-21037 Body_part denotes Pancreas http://purl.obolibrary.org/obo/UBERON_0001264

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 47-55 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 165-173 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 294-302 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 359-365 Disease denotes Cancer http://purl.obolibrary.org/obo/MONDO_0004992
T5 444-452 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 560-577 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T8 571-577 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T9 732-740 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T10 1218-1226 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T11 1376-1384 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 1600-1608 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T13 1693-1712 Disease denotes pancreatic diseases http://purl.obolibrary.org/obo/MONDO_0002356
T14 1884-1892 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T15 1895-1903 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T16 1947-1955 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T17 1956-1966 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T18 2141-2149 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T19 2239-2256 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T21 2250-2256 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T22 2267-2286 Disease denotes pancreatic diseases http://purl.obolibrary.org/obo/MONDO_0002356
T23 2339-2345 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T24 2404-2412 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T25 2607-2615 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T26 2712-2718 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T27 2771-2788 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T29 2782-2788 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T30 2846-2854 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T31 3074-3082 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T32 3338-3346 Disease denotes Pancreas http://purl.obolibrary.org/obo/MONDO_0021040
T33 3521-3538 Disease denotes Pancreatic Cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T35 3555-3587 Disease denotes Pancreatic Ductal Adenocarcinoma http://purl.obolibrary.org/obo/MONDO_0005184
T36 3573-3587 Disease denotes Adenocarcinoma http://purl.obolibrary.org/obo/MONDO_0004970
T37 3649-3678 Disease denotes Cystic Tumors of the Pancreas http://purl.obolibrary.org/obo/MONDO_0044880
T38 3656-3662 Disease denotes Tumors http://purl.obolibrary.org/obo/MONDO_0005070
T39 3670-3678 Disease denotes Pancreas http://purl.obolibrary.org/obo/MONDO_0021040
T40 3965-3973 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T41 4148-4156 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T42 4455-4463 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T43 4951-4983 Disease denotes Pancreatic ductal adenocarcinoma http://purl.obolibrary.org/obo/MONDO_0005184
T44 4962-4983 Disease denotes ductal adenocarcinoma http://purl.obolibrary.org/obo/MONDO_0004953|http://purl.obolibrary.org/obo/MONDO_0005590
T46 4969-4983 Disease denotes adenocarcinoma http://purl.obolibrary.org/obo/MONDO_0004970
T47 4985-5001 Disease denotes bile duct cancer http://purl.obolibrary.org/obo/MONDO_0003059|http://purl.obolibrary.org/obo/MONDO_0005496|http://purl.obolibrary.org/obo/MONDO_0019087
T50 4995-5001 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T51 5016-5041 Disease denotes ampullary adenocarcinomas http://purl.obolibrary.org/obo/MONDO_0002670
T52 5026-5041 Disease denotes adenocarcinomas http://purl.obolibrary.org/obo/MONDO_0004970
T53 5043-5083 Disease denotes intraductal papillary mucinous neoplasms http://purl.obolibrary.org/obo/MONDO_0004286
T54 5085-5090 Disease denotes IPMNs http://purl.obolibrary.org/obo/MONDO_0004286
T55 5097-5129 Disease denotes pancreatic neuroendocrine tumors http://purl.obolibrary.org/obo/MONDO_0019954
T56 5123-5129 Disease denotes tumors http://purl.obolibrary.org/obo/MONDO_0005070
T57 5131-5136 Disease denotes pNETs http://purl.obolibrary.org/obo/MONDO_0019954
T58 5747-5755 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T59 6647-6655 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T60 6688-6696 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T61 6858-6866 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T62 6964-6972 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T63 7090-7098 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T64 7354-7362 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T65 8737-8745 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T66 8927-8935 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T67 9224-9232 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T68 9354-9373 Disease denotes pancreatic diseases http://purl.obolibrary.org/obo/MONDO_0002356
T69 9655-9663 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T70 9716-9733 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T72 9727-9733 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T73 9886-9894 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T74 9899-9905 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T75 10077-10085 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T76 10103-10109 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T77 10240-10246 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T78 10354-10360 Disease denotes tumors http://purl.obolibrary.org/obo/MONDO_0005070
T79 11010-11018 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T80 11372-11391 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T81 11693-11701 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T82 12048-12056 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T83 12087-12104 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T85 12098-12104 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T86 12309-12326 Disease denotes Pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T88 12320-12326 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T89 12590-12598 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T90 12788-12807 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T91 12960-12979 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T92 13013-13021 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T93 13129-13137 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T94 13177-13185 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T95 13678-13686 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T96 13751-13759 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T97 13925-13933 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T98 13934-13943 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T99 14059-14067 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T100 14108-14114 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T101 14320-14328 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T102 14329-14338 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T103 14388-14405 Disease denotes Pancreatic Cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T105 14462-14479 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T107 14473-14479 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T108 14899-14916 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T110 14910-14916 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T111 15156-15173 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T113 15167-15173 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T114 15370-15387 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T116 15381-15387 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T117 15492-15509 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T119 15503-15509 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T120 15547-15562 Disease denotes pancreas cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T122 15547-15555 Disease denotes pancreas http://purl.obolibrary.org/obo/MONDO_0021040
T123 15556-15562 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T124 15634-15651 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T126 15645-15651 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T127 15698-15706 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T128 15745-15762 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T130 15756-15762 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T131 15938-15946 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T132 15961-15978 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T134 15972-15978 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T135 16126-16132 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T136 16149-16157 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T137 16258-16266 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T138 16292-16298 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T139 16408-16425 Disease denotes Pancreatic Cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T141 16458-16481 Disease denotes distal bile duct cancer http://purl.obolibrary.org/obo/MONDO_0003707
T142 16465-16481 Disease denotes bile duct cancer http://purl.obolibrary.org/obo/MONDO_0003059|http://purl.obolibrary.org/obo/MONDO_0005496|http://purl.obolibrary.org/obo/MONDO_0019087
T145 16475-16481 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T146 16499-16516 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T148 16510-16516 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T149 16627-16644 Disease denotes pancreatic cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T151 16638-16644 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T152 16719-16748 Disease denotes extrahepatic bile duct cancer http://purl.obolibrary.org/obo/MONDO_0003090|http://purl.obolibrary.org/obo/MONDO_0021321
T154 16732-16748 Disease denotes bile duct cancer http://purl.obolibrary.org/obo/MONDO_0003059|http://purl.obolibrary.org/obo/MONDO_0005496|http://purl.obolibrary.org/obo/MONDO_0019087
T157 16742-16748 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T158 16767-16791 Disease denotes duodenal adenocarcinomas http://purl.obolibrary.org/obo/MONDO_0006186
T159 16776-16791 Disease denotes adenocarcinomas http://purl.obolibrary.org/obo/MONDO_0004970
T160 17017-17034 Disease denotes ampullary cancers http://purl.obolibrary.org/obo/MONDO_0017590
T161 17087-17104 Disease denotes bowel obstruction http://purl.obolibrary.org/obo/MONDO_0004565
T162 17344-17363 Disease denotes Pancreatic Diseases http://purl.obolibrary.org/obo/MONDO_0002356
T163 17434-17453 Disease denotes pancreatic diseases http://purl.obolibrary.org/obo/MONDO_0002356
T164 17465-17470 Disease denotes IPMNs http://purl.obolibrary.org/obo/MONDO_0004286
T165 17472-17477 Disease denotes pNETs http://purl.obolibrary.org/obo/MONDO_0019954
T166 17479-17499 Disease denotes chronic pancreatitis http://purl.obolibrary.org/obo/MONDO_0005003
T167 17487-17499 Disease denotes pancreatitis http://purl.obolibrary.org/obo/MONDO_0004982
T168 17589-17609 Disease denotes chronic pancreatitis http://purl.obolibrary.org/obo/MONDO_0005003
T169 17597-17609 Disease denotes pancreatitis http://purl.obolibrary.org/obo/MONDO_0004982
T170 17655-17660 Disease denotes pNETs http://purl.obolibrary.org/obo/MONDO_0019954
T171 17713-17718 Disease denotes pNETs http://purl.obolibrary.org/obo/MONDO_0019954
T172 17722-17727 Disease denotes IPMNs http://purl.obolibrary.org/obo/MONDO_0004286
T173 18044-18052 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T174 18845-18853 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T175 19774-19793 Disease denotes pancreatic diseases http://purl.obolibrary.org/obo/MONDO_0002356
T176 20115-20123 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T177 20281-20289 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T178 20290-20309 Disease denotes pancreatic diseases http://purl.obolibrary.org/obo/MONDO_0002356
T179 20397-20418 Disease denotes periampullary cancers http://purl.obolibrary.org/obo/MONDO_0004465
T180 20423-20446 Disease denotes distal bile duct cancer http://purl.obolibrary.org/obo/MONDO_0003707
T181 20430-20446 Disease denotes bile duct cancer http://purl.obolibrary.org/obo/MONDO_0003059|http://purl.obolibrary.org/obo/MONDO_0005496|http://purl.obolibrary.org/obo/MONDO_0019087
T184 20440-20446 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T185 20465-20490 Disease denotes ampullary adenocarcinomas http://purl.obolibrary.org/obo/MONDO_0002670
T186 20475-20490 Disease denotes adenocarcinomas http://purl.obolibrary.org/obo/MONDO_0004970
T187 20592-20600 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T188 20697-20705 Disease denotes Pancreas http://purl.obolibrary.org/obo/MONDO_0021040
T189 20880-20897 Disease denotes Pancreatic Cancer http://purl.obolibrary.org/obo/MONDO_0005192|http://purl.obolibrary.org/obo/MONDO_0009831
T191 20914-20946 Disease denotes Pancreatic Ductal Adenocarcinoma http://purl.obolibrary.org/obo/MONDO_0005184
T192 20932-20946 Disease denotes Adenocarcinoma http://purl.obolibrary.org/obo/MONDO_0004970
T193 21008-21037 Disease denotes Cystic Tumors of the Pancreas http://purl.obolibrary.org/obo/MONDO_0044880
T194 21015-21021 Disease denotes Tumors http://purl.obolibrary.org/obo/MONDO_0005070
T195 21029-21037 Disease denotes Pancreas http://purl.obolibrary.org/obo/MONDO_0021040

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 75-84 http://purl.obolibrary.org/obo/BFO_0000030 denotes Objective
T2 90-93 http://purl.obolibrary.org/obo/PR_000001343 denotes aim
T3 923-924 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T4 1762-1763 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 1821-1833 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T6 1849-1850 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T7 1916-1918 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T8 2100-2101 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9 3338-3346 http://purl.obolibrary.org/obo/UBERON_0001264 denotes Pancreas
T10 3670-3678 http://purl.obolibrary.org/obo/UBERON_0001264 denotes Pancreas
T11 3706-3709 http://purl.obolibrary.org/obo/CLO_0050167 denotes LLC
T12 3899-3901 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T13 4275-4282 http://www.ebi.ac.uk/efo/EFO_0000881 denotes Digital
T14 4509-4510 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T15 4985-4994 http://purl.obolibrary.org/obo/UBERON_0002394 denotes bile duct
T16 5192-5193 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T17 5218-5219 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T18 5587-5589 http://purl.obolibrary.org/obo/CLO_0009877 denotes NY
T19 5810-5814 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T20 6014-6020 http://purl.obolibrary.org/obo/UBERON_0002415 denotes tailed
T21 6060-6061 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T22 6523-6525 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T23 6718-6721 http://purl.obolibrary.org/obo/CLO_0054057 denotes 181
T24 8219-8221 http://purl.obolibrary.org/obo/CLO_0054055 denotes 71
T25 8413-8422 http://purl.obolibrary.org/obo/BFO_0000030 denotes objective
T26 9034-9041 http://www.ebi.ac.uk/efo/EFO_0000881 denotes Digital
T27 9443-9444 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T28 9484-9485 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T29 9542-9549 http://www.ebi.ac.uk/efo/EFO_0000881 denotes Digital
T30 10124-10125 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T31 10633-10635 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T32 11823-11824 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T33 12412-12413 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T34 12509-12512 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T35 12630-12631 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T36 12645-12654 http://purl.obolibrary.org/obo/BFO_0000030 denotes objective
T37 13199-13206 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T38 13244-13245 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T39 13343-13348 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T40 13432-13437 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes Virus
T41 13502-13506 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T42 13589-13590 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T43 13760-13767 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T44 14595-14597 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T45 14647-14656 http://purl.obolibrary.org/obo/BFO_0000030 denotes objective
T46 15137-15138 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T47 15537-15546 http://purl.obolibrary.org/obo/BFO_0000030 denotes objective
T48 15547-15555 http://purl.obolibrary.org/obo/UBERON_0001264 denotes pancreas
T49 15677-15679 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T50 15721-15722 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T51 16071-16074 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T52 16465-16474 http://purl.obolibrary.org/obo/UBERON_0002394 denotes bile duct
T53 16550-16552 http://purl.obolibrary.org/obo/CLO_0054055 denotes 71
T54 16732-16741 http://purl.obolibrary.org/obo/UBERON_0002394 denotes bile duct
T55 16871-16873 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T56 16883-16884 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T57 17248-17250 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T58 18542-18545 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T59 18599-18604 http://purl.obolibrary.org/obo/UBERON_0000178 denotes blood
T60 18599-18604 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T61 18611-18618 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T62 19464-19465 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T63 19803-19804 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T64 19920-19921 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T65 20430-20439 http://purl.obolibrary.org/obo/UBERON_0002394 denotes bile duct
T66 20697-20705 http://purl.obolibrary.org/obo/UBERON_0001264 denotes Pancreas
T67 21029-21037 http://purl.obolibrary.org/obo/UBERON_0001264 denotes Pancreas
T68 21103-21110 http://www.ebi.ac.uk/efo/EFO_0000881 denotes Digital
T69 21156-21163 http://www.ebi.ac.uk/efo/EFO_0000881 denotes Digital
T70 21209-21216 http://www.ebi.ac.uk/efo/EFO_0000881 denotes Digital
T71 21262-21269 http://www.ebi.ac.uk/efo/EFO_0000881 denotes Digital
T72 21315-21322 http://www.ebi.ac.uk/efo/EFO_0000881 denotes Digital

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 5587-5589 Chemical denotes NY http://purl.obolibrary.org/obo/CHEBI_73427
T2 8059-8064 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T3 9849-9857 Chemical denotes adjuvant http://purl.obolibrary.org/obo/CHEBI_60809
T4 10187-10195 Chemical denotes adjuvant http://purl.obolibrary.org/obo/CHEBI_60809
T5 10306-10314 Chemical denotes adjuvant http://purl.obolibrary.org/obo/CHEBI_60809
T6 19822-19827 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 17525-17533 http://purl.obolibrary.org/obo/GO_0070265 denotes necrosis
T2 17525-17533 http://purl.obolibrary.org/obo/GO_0019835 denotes necrosis
T3 17525-17533 http://purl.obolibrary.org/obo/GO_0008219 denotes necrosis
T4 17525-17533 http://purl.obolibrary.org/obo/GO_0001906 denotes necrosis
T5 17633-17641 http://purl.obolibrary.org/obo/GO_0070265 denotes necrosis
T6 17633-17641 http://purl.obolibrary.org/obo/GO_0019835 denotes necrosis
T7 17633-17641 http://purl.obolibrary.org/obo/GO_0008219 denotes necrosis
T8 17633-17641 http://purl.obolibrary.org/obo/GO_0001906 denotes necrosis

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-64 Sentence denotes Global Survey on Pancreatic Surgery During the COVID-19 Pandemic
T2 66-74 Sentence denotes Abstract
T3 75-85 Sentence denotes Objective:
T4 86-263 Sentence denotes The aim of this study was to clarify the role of pancreatic surgery during the COVID-19 pandemic to optimize patients’ and clinicians’ safety and safeguard health care capacity.
T5 265-289 Sentence denotes Summary Background Data:
T6 290-358 Sentence denotes The COVID-19 pandemic heavily impacts health care systems worldwide.
T7 359-578 Sentence denotes Cancer patients appear to have an increased risk for adverse events when infected by COVID-19, but the inability to receive oncological care seems may be an even larger threat, particularly in case of pancreatic cancer.
T8 580-588 Sentence denotes Methods:
T9 589-806 Sentence denotes An online survey was submitted to all members of seven international pancreatic associations and study groups, investigating the impact of the COVID-19 pandemic on pancreatic surgery using 21 statements (April, 2020).
T10 807-912 Sentence denotes Consensus was defined as >80% agreement among respondents and moderate agreement as 60% to 80% agreement.
T11 914-922 Sentence denotes Results:
T12 923-1027 Sentence denotes A total of 337 respondents from 267 centers and 37 countries spanning 5 continents completed the survey.
T13 1028-1127 Sentence denotes Most respondents were surgeons (n = 302, 89.6%) and working in an academic center (n = 286, 84.9%).
T14 1128-1349 Sentence denotes The majority of centers (n = 166, 62.2%) performed less pancreatic surgery because of the COVID-19 pandemic, reducing the weekly pancreatic resection rate from 3 [interquartile range (IQR) 2–5] to 1 (IQR 0–2) (P < 0.001).
T15 1350-1428 Sentence denotes Most centers screened for COVID-19 before pancreatic surgery (n = 233, 87.3%).
T16 1429-1513 Sentence denotes Consensus was reached on 13 statements and 5 statements achieved moderate agreement.
T17 1515-1527 Sentence denotes Conclusions:
T18 1528-1802 Sentence denotes This global survey elucidates the role of pancreatic surgery during the COVID-19 pandemic, regarding patient selection for the surgical and oncological treatment of pancreatic diseases to support clinical decision-making and creating a starting point for further discussion.
T19 1804-2288 Sentence denotes The World Health Organization (WHO) declared a pandemic of coronavirus disease (COVID-19) (SARS-CoV-2) on March 11, 2020.1 The rapid spread of COVID-19 infections heavily impacts health care systems worldwide, resulting in limitations in both hospital and intensive care unit (ICU) capacity.2 As a result, this pandemic not only affects COVID-19 patients, but strikes the entire health care system including the care for patients with pancreatic cancer and other pancreatic diseases.3
T20 2289-2616 Sentence denotes Recent large series suggest an increased risk for cancer patients to develop severe complications when infected by COVID-19, including those who were treated with surgery or chemotherapy in the last month.4 Pursuing oncological care exposes both health care professionals and vulnerable patients to become infected by COVID-19.
T21 2617-2971 Sentence denotes However, the inability to receive medical and/or surgical care seems to be an equal threat for cancer patients as well.5 The highly aggressive biology of pancreatic cancer requires the continuation of oncological care during the COVID-19 pandemic,6,7 but an unambiguous strategy is needed to support health care professionals in clinical decision-making.
T22 2972-3196 Sentence denotes Therefore, this international survey study aimed to clarify the role of pancreatic surgery during the COVID-19 pandemic through 21 statements, aiming to optimize safety for patients and clinicians, and safeguard health care.
T23 3198-3205 Sentence denotes METHODS
T24 3207-3213 Sentence denotes Survey
T25 3214-3726 Sentence denotes An online survey was designed and submitted to all members of 7 international pancreatic associations and study groups: the Pancreas Club, European Pancreatic Club, Chinese Pancreatic Surgery Association, European Consortium on Minimally Invasive Pancreatic Surgery, Study Group of Preoperative Therapy for Pancreatic Cancer, Study Group of Pancreatic Ductal Adenocarcinoma with Peritoneal Metastasis, and International Study Group on Cystic Tumors of the Pancreas using Google Forms (Google LLC, Menlo Park CA).
T26 3727-3874 Sentence denotes Both surgeons and nonsurgeons (eg, gastroenterologists and medical oncologists) were asked to participate in this survey to balance the discussion.
T27 3875-4166 Sentence denotes The survey consisted of 36 questions on baseline characteristics, the local impact of the COVID-19 pandemic on pancreatic surgery (ie, number of pancreatic resections, triage, and screening), and 21 statements about the role of pancreatic surgery in the current era of the COVID-19 pandemic.
T28 4167-4250 Sentence denotes Each statement had to be appraised using 3 options: agree, disagree, and uncertain.
T29 4251-4309 Sentence denotes See Text – Supplemental Digital Content 1, for the survey.
T30 4310-4370 Sentence denotes The survey was conducted in the first 2 weeks of April 2020.
T31 4371-4549 Sentence denotes Nonrespondents were reminded twice because of the rapid developments in the current COVID-19 crisis and need for novel policy development a relatively short time window was used.
T32 4550-4683 Sentence denotes Respondents were asked to register their name and institution to prevent overlap of members between the above-mentioned associations.
T33 4684-4777 Sentence denotes The response rate could not be calculated since associations submitted the survey themselves.
T34 4778-4937 Sentence denotes All study procedures were reviewed and approved by the Colorado Multiple Institutional Review Board (COMIRB) (protocol #20-0843) at the University of Colorado.
T35 4939-4950 Sentence denotes Definitions
T36 4951-5434 Sentence denotes Pancreatic ductal adenocarcinoma, bile duct cancer, duodenal and ampullary adenocarcinomas, intraductal papillary mucinous neoplasms (IPMNs), and pancreatic neuroendocrine tumors (pNETs) were defined in accordance to the WHO definitions.8,9 A hospital was defined as a high-volume pancreatic center when performing ≥20 pancreatoduodenectomies annually.10 Consensus was defined as >80% agreement among respondents and moderate agreement was defined as 60% to 80% agreement among them.
T37 5436-5456 Sentence denotes Statistical Analysis
T38 5457-5591 Sentence denotes Variables were processed and analyzed using IBM SPSS Statistics for Microsoft Windows version 26 (IBM Corp., Orchard Road Armonk, NY).
T39 5592-5681 Sentence denotes Data were reported as number with percentage or as median with interquartile range (IQR).
T40 5682-5854 Sentence denotes The weekly volume of pancreatic resections before and during the COVID-19 pandemic was compared, using the Wilcoxon signed-rank test for non-normally distributed variables.
T41 5855-5968 Sentence denotes Sensitivity analyses were performed to investigate the influence of specialty, the type of center, and continent.
T42 5969-6036 Sentence denotes Statistical significance was considered as 2-tailed P value <0.050.
T43 6038-6045 Sentence denotes RESULTS
T44 6047-6059 Sentence denotes Participants
T45 6060-6171 Sentence denotes A total of 337 respondents from 267 centers and 37 countries spanning 5 continents completed the online survey.
T46 6172-6225 Sentence denotes See Figure 1 for the number of responses per country.
T47 6226-6359 Sentence denotes Most respondents were working in an academic center (n = 286, 84.9%) and the majority of participants were surgeons (n = 302, 89.6%).
T48 6360-6415 Sentence denotes See Table 1 for the characteristics of the respondents.
T49 6416-6552 Sentence denotes The median annual hospital and individual surgeon volume of pancreatic resections were 75 (IQR 46–140) and 35 (IQR 20–60), respectively.
T50 6553-6595 Sentence denotes FIGURE 1 Number of responses per country.
T51 6596-6635 Sentence denotes TABLE 1 Characteristics of Respondents
T52 6637-6664 Sentence denotes Impact of COVID-19 Pandemic
T53 6665-6795 Sentence denotes During the peak of the COVID-19 pandemic, 67.8% (n = 181) of centers prioritized between different types of pancreatic resections.
T54 6796-6930 Sentence denotes Before pancreatic surgery, most centers screened patients for COVID-19 (n = 233, 87.3%), whereas some centers did not (n = 31, 11.6%).
T55 6931-6992 Sentence denotes See Table 2 for the preoperative COVID-19 screening strategy.
T56 6993-7108 Sentence denotes The majority of centers (n = 166, 62.2%) performed less pancreatic surgery as consequence of the COVID-19 pandemic.
T57 7109-7227 Sentence denotes From these centers, the weekly numbers of pancreatic resections decreased from 3 (IQR 2–5) to 1 (IQR 0–2) (P < 0.001).
T58 7228-7317 Sentence denotes In addition, 30.7% (n = 51) of responding centers performed no pancreatic surgery at all.
T59 7318-7362 Sentence denotes TABLE 2 Preoperative Screening for COVID-19
T60 7364-7374 Sentence denotes Statements
T61 7375-7490 Sentence denotes Consensus was reached on 13 from the 21 statements (62%) and moderate agreement was achieved on 5 statements (24%).
T62 7491-7540 Sentence denotes The remaining 3 statements had an agreement <60%.
T63 7541-7586 Sentence denotes See Tables 3 to 5 for the statement outcomes.
T64 7587-7624 Sentence denotes TABLE 3 Statement Outcomes—Consensus
T65 7625-7671 Sentence denotes TABLE 4 Statement Outcomes—Moderate Agreement
T66 7672-7714 Sentence denotes TABLE 5 Statement Outcomes——Low Agreement
T67 7716-7736 Sentence denotes Sensitivity Analyses
T68 7737-7868 Sentence denotes The statement outcomes barely changed after excluding the nonacademic centers, without any shifts in the 3 categories of agreement.
T69 7869-8092 Sentence denotes Exclusion of nonsurgeons lead to the movement of statement 5—regarding the prioritization of patients with limited/without comorbidity for surgery to increase the ICU capacity—to the lowest group of agreement (61.1%–59.9%).
T70 8093-8280 Sentence denotes Analyzing the outcomes of Europe (n = 149, 44.2%), Asia (n = 115, 34.1%), and the Americas (ie, North and South America) (n = 71, 21.1%) separately demonstrated some changes in agreement.
T71 8281-8458 Sentence denotes The European respondents did not reach consensus on statement 3 (76.5% agreement) regarding the prioritization of patients based on objective prognostic factors and comorbidity.
T72 8459-8632 Sentence denotes In contrast to the overall outcomes, Asia achieved consensus on statement 4 (81.7% agreement) to prioritize each patient for pancreatic surgery, based on prognostic factors.
T73 8633-8877 Sentence denotes Whereas Europe agreed on the importance of high-volume centers to operate high-risk patients during the COVID-19 pandemic (87.9% agreement), both Asia (75.7% agreement) and the Americas (76.1% agreement) did not reach consensus on statement 16.
T74 8878-9010 Sentence denotes The recommendation for preoperative screening on COVID-19 (statement 19) reached solely consensus (84.5% agreement) in the Americas.
T75 9011-9127 Sentence denotes See Table—Supplemental Digital Content 2–4, for the statement outcomes of Europe, Asia, and the Americas separately.
T76 9129-9139 Sentence denotes DISCUSSION
T77 9140-9264 Sentence denotes This global survey study aimed to clarify the role of pancreatic surgery during the COVID-19 pandemic through 21 statements.
T78 9265-9483 Sentence denotes The statements regarding patient selection for the oncological and surgical treatment of pancreatic diseases could assist clinicians in their clinical decision-making and create a starting point for further discussion.
T79 9484-9673 Sentence denotes A literature review was performed (see Table—Supplemental Digital Content 5, for the search strategy) to evaluate the current evidence about pancreatic surgery during the COVID-19 pandemic.
T80 9674-9866 Sentence denotes Kutikov et al6 concluded that (suspected) pancreatic cancer does not allow any treatment delay and, therefore, requires immediate surgical treatment, but did not address (neo)adjuvant therapy.
T81 9867-10264 Sentence denotes Patients with both COVID-19 and cancer or treated with chemotherapy/surgery in the last months seem to be at risk for severe events (ie, ICU admission requiring invasive ventilation, or death) in comparison to COVID-19 patients without cancer, according to a Chinese series.4 Therefore, Liang et al4 advised to postpone adjuvant chemotherapy or elective surgery for stable cancer in endemic areas.
T82 10265-10418 Sentence denotes In contrast, Ueda et al7 emphasized that adjuvant therapy with curative intent for solid tumors should proceed, and surgery needs prioritization as well.
T83 10419-11160 Sentence denotes This latter statement is supported by the Society of Surgical Oncology (SSO), stating that hepato-pancreato-biliary malignancies are typically aggressive and, therefore, should not be considered as “elective” care.11 In addition, the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and the European Association of Endoscopic Surgery recommended to postpone all elective surgery with exception of surgical care for life threatening diseases such as progressive malignancies.12 Nevertheless, the limited evidence regarding the role of pancreatic surgery in the era of the COVID-19 pandemic underlines the need for an international survey with clear statements, aiming to guide clinicians in their clinical decision-making.
T84 11161-11316 Sentence denotes The statement outcomes of the present international expert survey revealed several consensus statements as well as statements that need further discussion.
T85 11318-11324 Sentence denotes Triage
T86 11325-11503 Sentence denotes Patients with increased risk for postoperative respiratory failure should not be prioritized for surgery in absence of full hospital capacity, according to consensus statement 6.
T87 11504-11711 Sentence denotes In contrast, only 61% agreement was reached on statement 5 comprising the proposition for surgery only for patients with limited/without comorbidity to minimize the use of ICU capacity for COVID-19 patients.
T88 11712-12379 Sentence denotes The American College of Surgeons (ACS) underlined consensus statement 6, stating that “For elective cases with a high likelihood of postoperative ICU or respirator utilization, it will be more imperative that the risk of delay to the individual patient is balanced against the imminent availability of these resources for patients with COVID-19.”13 The aggressive biology of pancreatic cancer justifies elective pancreatic surgery as indispensable care12 and, therefore, should not be exclusively performed for very low risk patients as prevention to overload hospital resources (see the section “Pancreatic cancer” below for further explanation and recommendations).
T89 12380-12443 Sentence denotes This could be the rationale for a low agreement on statement 5.
T90 12444-12982 Sentence denotes The ACS emphasized that continuation of “elective” surgical care has to be frequently evaluated and adapted if needed, based on the impact of the COVID-19 pandemic on local resources.13 A reliable and objective model is needed to stratify patients and guide prioritization in accordance to hospital capabilities, such as the recently developed respiratory failure risk score for elective abdominal and vascular surgery, that identified pancreatic surgery among others as an independent risk factor for postoperative respiratory failure.14
T91 12984-13021 Sentence denotes Screening and Protection for COVID-19
T92 13022-13138 Sentence denotes Before pancreatic surgery, most centers represented in this survey screened their patients for symptoms of COVID-19.
T93 13139-13232 Sentence denotes No consensus was reached to recommend COVID-19 preoperative testing/screening (statement 19).
T94 13233-13381 Sentence denotes This seems a plea to obligate some type of screening, but not necessarily with PCR and/or computed tomography chest, particularly considering SAGES.
T95 13382-13802 Sentence denotes SAGES underlines the recommendation of the Corona Virus Global Surgical Collaborative to perform some type of screening test for all patients (even if asymptomatic and without risk factors) who will undergo a surgical or interventional endoscopic procedure in institutions seeing high volumes of COVID-19 patients.12 In addition, ACS advised to wait for the results of COVID-19 testing in patients who may be infected.13
T96 13803-14140 Sentence denotes Based on consensus, patients who will undergo pancreatic surgery should be informed about the following additional risks: COVID-19 infection during hospitalization, possible nonoptimal postoperative management (ie, shortage of ICU beds), increased risk of COVID-19 related mortality due to surgery or the cancer condition (statement 17).
T97 14141-14386 Sentence denotes Furthermore, this survey convincingly recommends that operating room (OR) personnel have to wear adequate protective features during surgery, considering their increased risk for COVID-19 infection during surgical procedures (statement 20).15,16
T98 14388-14405 Sentence denotes Pancreatic Cancer
T99 14406-14723 Sentence denotes According to the consensus statements for patients with pancreatic cancer, each patient should be operated after completing neoadjuvant therapy (statement 1), as is also advised by the SSO.11 However, patients should be prioritized based on objective prognostic factors and comorbidities in case of limited resources.
T100 14724-14943 Sentence denotes If surgery is postponed, patients should continue with neoadjuvant therapy (statement 3), but neoadjuvant therapy should not be used to select each patient with nonmetastatic pancreatic cancer for surgery (statement 2).
T101 14944-15092 Sentence denotes Subsequently, patients with postponed surgery need to be evaluated as soon as possible for surgery when resources are available again (statement 7).
T102 15093-15308 Sentence denotes Oba et al17 recently described the value of a new nomogram for pancreatic cancer, estimating patients’ predicted survival based on preoperative factors and confirmed the prognostic power of known predictive factors.
T103 15309-15417 Sentence denotes These models could be used for prioritization of surgery for pancreatic cancer in case of limited resources.
T104 15418-15652 Sentence denotes However, no consensus was reached on statement 4 and 5 to prioritize each pancreatic cancer patient on comorbidity and objective pancreas cancer-related prognostic factors, considering the life threatening nature of pancreatic cancer.
T105 15653-15870 Sentence denotes Nevertheless, statement 18—prioritization of COVID-19 patients with a better prognosis over pancreatic cancer patients adhering to the process of triage for hospital resources and ICU beds—did not reach 60% agreement.
T106 15871-15994 Sentence denotes However, the difficulty to prioritize between patients with severe COVID-19 or resectable pancreatic cancer is conceivable.
T107 15995-16064 Sentence denotes See the section “Triage” for further explanation and recommendations.
T108 16065-16370 Sentence denotes Italy has demonstrated the feasibility of continuing crucial cancer care during the COVID-19 pandemic, among others by appropriate resource allocation and separate health care pathways between COVID-19 patients and noninfected cancer patients, structured by performance criteria (eg, hospital volume).3,18
T109 16372-16426 Sentence denotes Periampullary Malignancies (Without Pancreatic Cancer)
T110 16427-16517 Sentence denotes Statement 8 proposed to manage distal bile duct cancer as equivalent to pancreatic cancer.
T111 16518-16698 Sentence denotes However, the lack of consensus (71%) implies that surgery might have slightly less priority in comparison to pancreatic cancer since 23% of respondents disagreed on the other hand.
T112 16699-17106 Sentence denotes The SSO stated that extrahepatic bile duct cancer and ampullary and duodenal adenocarcinomas should be operated as soon as feasible, regardless of the presence of symptoms.11 However, a high disagreement rate (40%) was reached on statement 15 for postponing surgery or giving neoadjuvant chemotherapy for duodenal and ampullary cancers in absence of life threatening risks (ie, bleeding, bowel obstruction).
T113 17107-17319 Sentence denotes Since evidence is limited about the efficacy of neoadjuvant chemotherapy for these cancers so far and could not be deemed to stable diseases,11 many physicians might thought these should be resected as indicated.
T114 17321-17363 Sentence denotes Benign or Premalignant Pancreatic Diseases
T115 17364-17534 Sentence denotes Consensus was reached to postpone surgery for benign and premalignant pancreatic diseases, including IPMNs, pNETs, chronic pancreatitis, and infected pancreatic necrosis.
T116 17535-17776 Sentence denotes Exceptions comprise life threatening complications of chronic pancreatitis or infected pancreatic necrosis, symptomatic pNETs without effective alternative treatment options, or pNETs or IPMNs with suspicion for malignancy (statements 9–14).
T117 17778-17794 Sentence denotes High-Volume Care
T118 17795-18169 Sentence denotes Volume–outcome relationships in pancreatic surgery are well established with shorter hospital stay and lower mortality in high-volume centers.10,19,20 Pancreatic surgery in high-risk patients should not be performed in low-volume centers during the COVID-19 pandemic, aiming to reduce the risk of long hospital stay and major complications requiring ICU care (statement 16).
T119 18170-18288 Sentence denotes Remarkably, the sensitivity analysis revealed that only Europe reached consensus in contrast to Asia and the Americas.
T120 18290-18316 Sentence denotes Minimally Invasive Surgery
T121 18317-18514 Sentence denotes Statement 21 demonstrated the limited evidence regarding the safety of minimally invasive surgery, illustrated by the substantial percentage of respondents who agreed (65%) or were uncertain (24%).
T122 18515-18747 Sentence denotes Although previous research has shown that laparoscopy can lead to aerosolization of blood borne viruses,21,16,15 SAGES advised to continue to perform minimally invasive surgery in accordance to their risk reducing procedural advice.
T123 18748-19359 Sentence denotes SAGES will monitor emerging evidence considering the limited evidence about the relative risk of COVID-19 spreading in the OR by minimally invasive surgery in comparison to conventional open surgery.12 The ACS mentioned that aerosol-generating procedures increase the risk for OR personnel and may not be avoidable, but confirmed the insufficiency of evidence to recommend or discommend minimally invasive surgery.13 Meanwhile, SAGES underlined the proven benefits of minimally invasive surgery to reduce postoperative morbidity and hospital stay and, therefore, should be strongly considered in these patients.
T124 19361-19386 Sentence denotes Strengths and Limitations
T125 19387-19505 Sentence denotes The strength of this survey is the global range of respondents, representing a wide range of countries and continents.
T126 19506-19578 Sentence denotes However, the results should be interpreted in light of some limitations.
T127 19579-19794 Sentence denotes First, only 10.4% nonsurgeons (eg, medical oncologists and gastroenterologists) participated in this survey, which could possibly outbalance the discussion regarding the oncological treatment of pancreatic diseases.
T128 19795-19907 Sentence denotes Second, a relatively small group of 8 countries was responsible for the majority of survey participants (76.6%).
T129 19908-19983 Sentence denotes Third, only a minority of participants represented the nonacademic centers.
T130 19985-19996 Sentence denotes CONCLUSIONS
T131 19997-20310 Sentence denotes In summary, this survey reached consensus on the majority of statements for the role of pancreatic surgery during the COVID-19 pandemic to optimize safety for patients and clinicians and safeguard health care capacity by prioritizing only the most relevant care for patients with non-COVID-19 pancreatic diseases.
T132 20311-20610 Sentence denotes The statements maybe be updated, based on more solid evidence about the management of periampullary cancers (ie distal bile duct cancer, and duodenal and ampullary adenocarcinomas), preoperative screening modalities, and the safety of minimally invasive surgery in relation to the COVID-19 pandemic.
T133 20612-20626 Sentence denotes Acknowledgment
T134 20627-21065 Sentence denotes The authors thank all participating members and the leadership of the Pancreas Club, European Pancreatic Club, Chinese Pancreatic Surgery Association, European Consortium on Minimally Invasive Pancreatic Surgery, Study Group of Preoperative Therapy for Pancreatic Cancer, Study Group of Pancreatic Ductal Adenocarcinoma with Peritoneal Metastasis, and International Study Group on Cystic Tumors of the Pancreas for supporting this survey.
T135 21067-21089 Sentence denotes Supplementary Material
T136 21090-21118 Sentence denotes Supplemental Digital Content
T137 21120-21142 Sentence denotes Supplementary Material
T138 21143-21171 Sentence denotes Supplemental Digital Content
T139 21173-21195 Sentence denotes Supplementary Material
T140 21196-21224 Sentence denotes Supplemental Digital Content
T141 21226-21248 Sentence denotes Supplementary Material
T142 21249-21277 Sentence denotes Supplemental Digital Content
T143 21279-21301 Sentence denotes Supplementary Material
T144 21302-21330 Sentence denotes Supplemental Digital Content
T145 21332-21395 Sentence denotes S.S, C.L.W., M.A.H., M.G.B., and M.D.C. are shared supervisors.
T146 21396-21446 Sentence denotes A.O. and T.F.S. contributed equally to this study.
T147 21447-22130 Sentence denotes Authors’ contributions: A.O., T.F.S., S.S., C.L.W., M.A.H., M.G.B., and M.D.C. contributed to the conception and designed the study; A.O., T.F.S., M.H.A., M.G.B., and M.D.C. managed the project; A.O., T.F.S., M.L., T.H., N.Z., W.H.N., M.U., R.D.S., W.W., Y.Z., S.S., C.L.W., M.A.H., M.G.B., and M.D.C. contributed to the acquisition, analysis, and interpretation of data; A.O., T.F.S., M.G.B., and M.D.C. participated in drafting the article; M.L., T.H., N.Z., W.H.N., M.U., R.D.S., M.H.A., W.W., Y.Z., S.S., C.L.W., and M.A.H. participated in revising the article critically for important intellectual content; all authors gave final approval of the final manuscript for submission.
T148 22131-22175 Sentence denotes The authors report no conflicts of interest.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 359-365 Phenotype denotes Cancer http://purl.obolibrary.org/obo/HP_0002664
T2 560-577 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T3 1693-1712 Phenotype denotes pancreatic diseases http://purl.obolibrary.org/obo/HP_0001732
T4 2239-2256 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T5 2267-2286 Phenotype denotes pancreatic diseases http://purl.obolibrary.org/obo/HP_0001732
T6 2339-2345 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T7 2712-2718 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T8 2771-2788 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T9 3521-3538 Phenotype denotes Pancreatic Cancer http://purl.obolibrary.org/obo/HP_0002894
T10 4985-5001 Phenotype denotes bile duct cancer http://purl.obolibrary.org/obo/HP_0030153
T11 5065-5083 Phenotype denotes mucinous neoplasms http://purl.obolibrary.org/obo/HP_0031495
T12 9354-9373 Phenotype denotes pancreatic diseases http://purl.obolibrary.org/obo/HP_0001732
T13 9716-9733 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T14 9899-9905 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T15 10103-10109 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T16 10240-10246 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T17 10481-10489 Phenotype denotes Oncology http://purl.obolibrary.org/obo/HP_0002664
T18 11372-11391 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T19 12087-12104 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T20 12309-12326 Phenotype denotes Pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T21 12788-12807 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T22 12960-12979 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T23 14108-14114 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T24 14388-14405 Phenotype denotes Pancreatic Cancer http://purl.obolibrary.org/obo/HP_0002894
T25 14462-14479 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T26 14899-14916 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T27 15156-15173 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T28 15370-15387 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T29 15492-15509 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T30 15556-15562 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T31 15634-15651 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T32 15745-15762 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T33 15961-15978 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T34 16126-16132 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T35 16292-16298 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T36 16408-16425 Phenotype denotes Pancreatic Cancer http://purl.obolibrary.org/obo/HP_0002894
T37 16465-16481 Phenotype denotes bile duct cancer http://purl.obolibrary.org/obo/HP_0030153
T38 16499-16516 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T39 16627-16644 Phenotype denotes pancreatic cancer http://purl.obolibrary.org/obo/HP_0002894
T40 16732-16748 Phenotype denotes bile duct cancer http://purl.obolibrary.org/obo/HP_0030153
T41 16767-16791 Phenotype denotes duodenal adenocarcinomas http://purl.obolibrary.org/obo/HP_0006771
T42 17087-17104 Phenotype denotes bowel obstruction http://purl.obolibrary.org/obo/HP_0005214
T43 17344-17363 Phenotype denotes Pancreatic Diseases http://purl.obolibrary.org/obo/HP_0001732
T44 17434-17453 Phenotype denotes pancreatic diseases http://purl.obolibrary.org/obo/HP_0001732
T45 17479-17499 Phenotype denotes chronic pancreatitis http://purl.obolibrary.org/obo/HP_0006280
T46 17589-17609 Phenotype denotes chronic pancreatitis http://purl.obolibrary.org/obo/HP_0006280
T47 19774-19793 Phenotype denotes pancreatic diseases http://purl.obolibrary.org/obo/HP_0001732
T48 20290-20309 Phenotype denotes pancreatic diseases http://purl.obolibrary.org/obo/HP_0001732
T49 20430-20446 Phenotype denotes bile duct cancer http://purl.obolibrary.org/obo/HP_0030153
T50 20880-20897 Phenotype denotes Pancreatic Cancer http://purl.obolibrary.org/obo/HP_0002894

2_test

Id Subject Object Predicate Lexical cue
32675507-22687371-3180345 5190-5191 22687371 denotes 9
32675507-26636243-3180346 5303-5305 26636243 denotes 10
32675507-32066541-3180347 10141-10142 32066541 denotes 4
32675507-32066541-3180348 10165-10166 32066541 denotes 4
32675507-27607099-3180349 12980-12982 27607099 denotes 14
32675507-24570016-3180350 14381-14383 24570016 denotes 15
32675507-27484956-3180351 14384-14386 27484956 denotes 16
32675507-26636243-3180352 17937-17939 26636243 denotes 10
32675507-27037200-3180353 17940-17942 27037200 denotes 19
32675507-29571615-3180354 17943-17945 29571615 denotes 20
32675507-16002179-3180355 18619-18621 16002179 denotes 21
32675507-27484956-3180356 18622-18624 27484956 denotes 16
32675507-24570016-3180357 18625-18627 24570016 denotes 15